CombiMatrix this week launched two new array-based diagnostic tests through its CombiMatrix Molecular Diagnostics subsidiary in Irvine, Calif.
The first is an update of its Bac HD Scan Test. The previous version of this test was designed to identify up to 125 genetic syndromes and disorders that are the cause of developmental problems in children, including Down, Prader-Willi, and DiGeorge syndromes. The newly updated version of this test now identifies more than 220 specific genetic syndromes.
Once a genetic aberration has been identified, CombiMatrix offers Zoom-in arrays, custom chips of up to 12,000 oligonucleotide probes designed using its CustomArray B3 Synthesizer on its CustomArray 12K platform, to provide higher resolution in the areas of the identified aberrations.